- Home
- IHRT vs ACIU Comparison
IHRT vs ACIU Comparison
Compare IHRT & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IHRT | ACIU |
|---|---|---|
| Founded | 1974 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 623.2M | 213.3M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IHRT | ACIU |
|---|---|---|
| Price | $4.17 | $3.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.50 | ★ $10.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 02-26-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,856,033,000.00 | $5,482,957.00 |
| Revenue This Year | $1.96 | N/A |
| Revenue Next Year | $5.62 | $644.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.39 | N/A |
| 52 Week Low | $0.95 | $1.43 |
| 52 Week High | $5.44 | $4.00 |
Technical Indicators
Market Signals| Indicator | IHRT | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 60.00 |
| Support Level | $4.31 | $3.09 |
| Resistance Level | $4.28 | $3.30 |
| Average True Range (ATR) | 0.22 | 0.22 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 24.34 | 66.86 |
Price Performance
Historical ComparisonAbout IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.